Health Care·Health Care Services·$21.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.18 | N/A | +0.08% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.18 | N/A | +0.08% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about market conditions affecting performance. They emphasized the importance of adapting to industry changes.
Management highlighted ongoing challenges in the healthcare sector.
They acknowledged the need for strategic adjustments moving forward.
The earnings report indicates that Quest Diagnostics faced challenges, reflected in the stock's 5.71% decline. The slight EPS beat suggests some resilience, but the lack of revenue data and guidance raises concerns. Investors may be cautious as the company navigates a tough healthcare landscape.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ICU MED INC
Oct 15, 2012